Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 11 Projects
Project # Contact PI Funding Organization Fiscal Year
Sativex in MCI patients at high risk of developing AD
PTC C-16-422407 Ferrer, Isidro Alzheimer's Association 2016
Clinical development of a companion marker for treatment with the dual LSD1/MAO-B inhibitor ORY-2001
GC-2012832 Maes, Tamara Alzheimer's Drug Discovery Foundation 2016
THERAPEUTIC USE OF EPIGENETIC MODULATORS IN ONCOLOGICAL AND NEURODEGENERATIVE DISEASE
EUJPND-CDTI-GENOMICS-1300 GENOMICS, ORYZON Centre for the Development of Industrial Technology 2016
MOLECULAR MODULATION OF EXTRASINAPTIC COMPLEXES OF NMDA RECEPTORS AS A THERAPEUTIC STRATEGY FOR ALZHEIMER'S DISEASE
EUJPND-SpainISC-ALTAFAJ TARDIO-1307 ALTAFAJ TARDIO, XAVIER INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
MULIDIDIAN CHIRAL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES: NICOTYL RECEPTOR LIGANDS, NRF2 AND ANTI-INFLAMMATORY INDUCTORS
EUJPND-SpainISC-LEON MARTINEZ-1349 LEON MARTINEZ, RAFAEL INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
STEP REGULATION BY BDNF: THERAPEUTIC IMPLICATIONS IN NEUROLOGICAL DISEASES
EUJPND-SpainISC-PEREZ NAVARRO-1365 PEREZ NAVARRO, ESTHER INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
PHOSPHATASE PROTEIN 2A AS A THERAPEUTIC DIAL FOR THE DEVELOPMENT OF NEW PHARMACIES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
EUJPND-SpainISC-RIOS SALGADO-1370 RIOS SALGADO, CRISTOBAL DE LOS INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
EFFECTIVENESS AND SAFETY OF A FRAGMENT OF BAPINEUZUMAB AS A THERAPY OF ALZHEIMER'S DISEASE IN A MURINO MODEL. IMPLICATION OF APOLIPOPROTEINS IN CLARIFICATION
EUJPND-SpainISC-VILLEGAS HERNANDEZ-1393 VILLEGAS HERNANDEZ, SANDRA INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
GSK-3ß AND ADULT NEUROGENESIS. THERAPEUTIC POTENTIAL FOR AD.
2015-NIRG-340709  Llorens-Martín, María Alzheimer's Association 2015
Preclinical development of ORY-2001, a dual LSD1/MAOB inhibitor for the treatment of Alzheimer disease.
GC-2012231 Maes, Tamara Alzheimer's Drug Discovery Foundation 2015